Abstract
At present, the vaccine authorized in children aged 5 years and older is the BNT162b2 messenger RNA COVID-19 vaccine. Unlike adults, there is limited data available in the pediatric age describing adverse events after vaccine. We report a case of adenomesenteritis in a young girl following the first dose of vaccine.
Author supplied keywords
Cite
CITATION STYLE
APA
Bloise, S., Marcellino, A., Martucci, V., Sanseviero, M., Testa, A., Del Giudice, E., … Lubrano, R. (2022). Adenomesenteritis following SARS-CoV-2 Vaccination in Children: A Case Report and Review of The Literature. Children, 9(7). https://doi.org/10.3390/children9070993
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free